Burling Wealth Partners, LLC Astrazeneca PLC Transaction History
Burling Wealth Partners, LLC
- $542 Billion
- Q2 2025
A detailed history of Burling Wealth Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Burling Wealth Partners, LLC holds 37,273 shares of AZN stock, worth $2.74 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
37,273
Previous 47,162
20.97%
Holding current value
$2.74 Million
Previous $3.47 Billion
24.86%
% of portfolio
0.48%
Previous 0.73%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
508MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.03 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...